《中国高血压防治指南(2024年修订版)》亮点、要点解读  

Interpretation to the highlights and key points of the Chinese Guidelines for Prevention and Treatment of Hypertension(Revised Edition 2024)

作　　者：刘嘉慧 刘靖[1] Liu Jiahui;Liu Jing(Hypertension Department,Peking University People's Hospital,Beijing 100044,China)

机构地区：[1]北京大学人民医院高血压科,北京100044

出　　处：《中国医学前沿杂志(电子版)》2025年第1期1-5,共5页Chinese Journal of the Frontiers of Medical Science(Electronic Version)

摘　　要：时隔6年,备受业界瞩目、由中国高血压联盟联合多个学术团体共同制定的《中国高血压防治指南(2024年修订版)》于近期正式公布,并在2024年7月《中华高血压杂志》全文发表。新版指南在2018年版基础上,结合国内外高血压及相关疾病领域最新研究成果进行修订,内容较前更加丰富,涵盖高血压防治与管理诸多方面。既延续经典的治疗原则,也纳入前沿的诊疗手段,继往开来,兼具教育性及实用性。值得一提的是,指南765篇参考文献中,60%为近5年内发表,超过1/3第一作者为中国学者,特别是来自中国的原创、高质量研究为新指南修订提供了丰富的临床证据,彰显近年来我国临床研究水平的大幅度提升。毫无疑问,新版指南将继续对我国高血压管理临床实践发挥重要指导作用。本文将对新版指南的重点更新之处进行梳理、解读,并与既往指南及近期发布的其他高血压指南进行比较,以飨读者。After 6 years,the“Guidelines for the Prevention and Treatment of Hypertension in China(2024 Revised Edition)”,which has attracted much attention and jointly formulated by the Chinese Hypertension Alliance and several academic groups,was officially announced recently and published in the full text of the Chinese Journal of Hypertension in July 2024.On the basis of the 2018 edition,the new version of the guidelines has been revised in combination with the latest research results in the field of hypertension and related diseases,and the content is richer than before,covering prevention and management of hypertension.It not only retains classic treatment principles but also includes cutting-edge diagnostic and therapeutic approaches,setting a new standard for the future.It is worth mentioning that 60%of the 765 references cited in the guidelines were published within the past 5 years,with over 1/3 of the first authors being Chinese scholars,particularly.And Chinese original,high-quality research provided abundant clinical evidence for the revision of the new guidelines,reflecting the significant improvement in China's clinical research level in recent years.There is no doubt that the update guidelines will continue to play a crucial role in guiding clinical practice of hypertension management in China.In this article,we will summarize and interpret the key updates in the revised guidelines,compare them with previous guidelines and other recently released hypertension guidelines,and present them to readers.

关 键 词：高血压 指南 解读 

分 类 号：R54[医药卫生—心血管疾病]